GlassScriptPhysician profile
Moath A Hamed
NPI 1245659390
$2,257.61
in general payments reported to CMS, 2019-2025
16 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $529 · 2023: $836 · 2024: $285 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $513.94 | 2024-2025 | Percept PC Brainsense |
| Abbvie INC. | $494.29 | 2022-2024 | |
| Abbott Laboratories | $327.34 | 2022-2023 | Infinity |
| Teva Pharmaceuticals USA, INC. | $296.41 | 2021-2023 | Austedo Xr |
| Boston Scientific Corporation | $165.00 | 2022 | |
| Horizon Therapeutics Plc | $150.00 | 2023 | Uplizna |
| Lilly USA, LLC | $72.93 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $48.61 | 2021 | |
| Neurocrine Biosciences, INC. | $35.84 | 2022 | |
| Biogen, INC. | $25.53 | 2022 | |
| Allergan, INC. | $24.98 | 2021 | |
| Sunovion Pharmaceuticals INC. | $23.33 | 2022 | |
| Sk Life Science, INC. | $22.02 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.58 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moath Hamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.